US Stock Market Move | Lilly (LLY.US) increased by nearly 2%, accumulating a total increase of 16% within the month.

On Wednesday, Eli Lilly (LLY.US) rose by nearly 2%, hitting a new all-time high and accumulating a 16% increase in the month. On the news front, Eli Lilly announced a medical insurance agreement with the US government, reducing the price of GLP-1 drugs to $245 per month in exchange for federal medical insurance coverage, opening up a new market of about 30 million people with an annual sales potential of $27 billion. Citigroup Inc. has significantly raised Eli Lilly's target price from $1250 to $1500, enhancing market recognition of the company's value.